Michael A. Perricone

A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis

F. Ruiz, John P. Clancy, Michael A. Perricone et al. · Human Gene Therapy · 2001 · 183 citations

Inflammatory Lung Disease, Immunodeficiencies, Immunology +17

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

Joseph Zabner, Shuk Han Cheng, David P. Meeker et al. · Journal of Clinical Investigation · 1997 · 177 citations · Full text

Molecular Biological Method, Medicine, Natural Sciences +11

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

Shingo Takano, Stephen Gately, Mary E. Neville et al. · PubMed · 1994 · 132 citations

Endothelial Cell Binding, Pathology, Pharmacotherapy +20

Aerosol and Lobar Administration of a Recombinant Adenovirus to Individuals with Cystic Fibrosis. I. Methods, Safety, and Clinical Implications

Patricia M. Joseph, Brian O’Sullivan, Allen Lapey et al. · Human Gene Therapy · 2001 · 100 citations

Aerosol and Lobar Administration of a Recombinant Adenovirus to Individuals with Cystic Fibrosis. II. Transfection Efficiency in Airway Epithelium

Michael A. Perricone, James E. Morris, K Pavelka et al. · Human Gene Therapy · 2001 · 92 citations